These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 8455944)
1. A cell culture model system for genetic analyses of the cell cycle by targeted homologous recombination. Prouty SM; Hanson KD; Boyle AL; Brown JR; Shichiri M; Follansbee MR; Kang W; Sedivy JM Oncogene; 1993 Apr; 8(4):899-907. PubMed ID: 8455944 [TBL] [Abstract][Full Text] [Related]
2. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation. Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849 [TBL] [Abstract][Full Text] [Related]
3. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Mateyak MK; Obaya AJ; Adachi S; Sedivy JM Cell Growth Differ; 1997 Oct; 8(10):1039-48. PubMed ID: 9342182 [TBL] [Abstract][Full Text] [Related]
4. Regulation of cell cycle duration by c-myc levels. Karn J; Watson JV; Lowe AD; Green SM; Vedeckis W Oncogene; 1989 Jun; 4(6):773-87. PubMed ID: 2660073 [TBL] [Abstract][Full Text] [Related]
5. Effects of c-raf-1 and c-myc expression on radiation response in an in vitro model of human small-cell-lung carcinoma. Pfeifer A; Mark G; Leung S; Dougherty M; Spillare E; Kasid U Biochem Biophys Res Commun; 1998 Nov; 252(2):481-6. PubMed ID: 9826556 [TBL] [Abstract][Full Text] [Related]
6. Regulation of c-myc expression by Ras/Raf signalling. Kerkhoff E; Houben R; Löffler S; Troppmair J; Lee JE; Rapp UR Oncogene; 1998 Jan; 16(2):211-6. PubMed ID: 9464539 [TBL] [Abstract][Full Text] [Related]
7. Transformation of hemopoietic cells by raf and myc oncogenes: a new perspective on lineage commitment. Klinken SP Cancer Cells; 1991 Oct; 3(10):373-82. PubMed ID: 1777358 [TBL] [Abstract][Full Text] [Related]
8. Proto-oncogene expression in human glomerular diseases. Takemura T; Okada M; Akano N; Murakami K; Hino S; Yagi K; Takekoshi Y; Yoshioka K J Pathol; 1996 Mar; 178(3):343-51. PubMed ID: 8778342 [TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc. Nass SJ; Dickson RB Clin Cancer Res; 1998 Jul; 4(7):1813-22. PubMed ID: 9676860 [TBL] [Abstract][Full Text] [Related]
10. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism. Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166 [TBL] [Abstract][Full Text] [Related]
11. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Chen HW; Huang HC Br J Pharmacol; 1998 Jul; 124(6):1029-40. PubMed ID: 9720770 [TBL] [Abstract][Full Text] [Related]
12. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells. Lepique AP; Moraes MS; Rocha KM; Eichler CB; Hajj GN; Schwindt TT; Armelin HA J Mol Endocrinol; 2004 Dec; 33(3):623-38. PubMed ID: 15591023 [TBL] [Abstract][Full Text] [Related]
13. Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis. Klock G; Storch S; Rickert J; Gutacker C; Koch-Brandt C J Cell Physiol; 1998 Dec; 177(4):593-605. PubMed ID: 10092212 [TBL] [Abstract][Full Text] [Related]
14. Regulation of cell cycle entry and G1 progression by CSF-1. Roussel MF Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358 [TBL] [Abstract][Full Text] [Related]
15. Cell cycle synchronization of FRTL5 cells. A physiological model system. Degrassi A; Monaco MC; Lisignoli G; Belvedere O; Toneguzzi S; Malangone W; Bonora ML; Piacentini A; Lavaroni S; Scarbolo M; Ambesi-Impiombato FS; Facchini A J Exp Clin Cancer Res; 1998 Dec; 17(4):527-32. PubMed ID: 10089079 [TBL] [Abstract][Full Text] [Related]
16. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer. Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447 [TBL] [Abstract][Full Text] [Related]
17. [Construction of antisense c-myc recombinant adenovirus and its anti-tumor effects on osteosarcoma cell lines MG-63 and U2OS]. Xie XK; Yang DS; Ye ZM; Tao HM Ai Zheng; 2005 Mar; 24(3):292-7. PubMed ID: 15757529 [TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of A-Raf and C-Raf mRNA expression by antisense oligodeoxynucleotides in rat vascular smooth muscle cells: role of A-Raf and C-Raf in serum-induced proliferation. Cioffi CL; Garay M; Johnston JF; McGraw K; Boggs RT; Hreniuk D; Monia BP Mol Pharmacol; 1997 Mar; 51(3):383-9. PubMed ID: 9058592 [TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant human transforming growth factor-beta 1 or/and interleukin-6 on growth inhibition and proto-oncogene c-myc expression in human leukemia cells. Feng R; Shen S; Hui H; Jin M Chin Med J (Engl); 1997 Nov; 110(11):847-50. PubMed ID: 9772416 [TBL] [Abstract][Full Text] [Related]
20. Proto-oncogene mRNA levels and activities of multiple transcription factors in C3H 10T 1/2 murine embryonic fibroblasts exposed to 835.62 and 847.74 MHz cellular phone communication frequency radiation. Goswami PC; Albee LD; Parsian AJ; Baty JD; Moros EG; Pickard WF; Roti Roti JL; Hunt CR Radiat Res; 1999 Mar; 151(3):300-9. PubMed ID: 10073668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]